Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Nov 25, 16:00
466.40 -14.15 (-2.94%)
Volume
AVERAGE VOLUME
5-Day
92,461
10-Day
97,923
30-Day
116,156
175,148
  • Prev. Close

    480.55

  • Open Price

    483.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Nov 25, 15:59
466.30 -14.20 (-2.96%)
Volume
AVERAGE VOLUME
5-Day
1,803,272
10-Day
1,903,827
30-Day
2,759,239
2,611,985
  • Prev. Close

    480.50

  • Open Price

    484.00

  • Bid Price (Qty.)

    466.30 (620)

  • Offer Price (Qty.)

    0.00 (0)

Top Public Shareholders

Quarter Ending : September 2020
Shareholding belonging to the category : "Public and holding more than 1% of the Total No.of Shares"
Name of the Shareholder Total Shares held Shares as % of Total No. of Shares
Ashish Dhawan 3,500,000 1.24%
IEPF 224,639 0.08%
HDFC TRUSTEE COMPANY LTD. A/C HDFC GROWTH OPPORTUNITIES FUND 6,348,232 2.25%
HSBC POOLED INVESTMENT FUND - HSBC POOLED ASIA PAC 7,870,746 2.79%
HSBC GLOBAL INVESTMENT FUNDS - ASIA EX JAPAN EQUIT 3,280,233 1.16%
Clearing Members 735,134 0.26%
Non-Resident Indian (NRI) 3,082,311 1.09%
NTASAIN DISCOVERY MASTER FUND 3,250,000 1.15%
Bodies Corporate 3,508,771 1.24%
Trusts 10,980 0%
Foreign Nationals 43,150 0.02%
Qualified Institutional Buyers 14,178,707 5.02%
Hdfc Life Insurance Company Limited 3,605,055 1.28%
Life Insurance Corporation of India 5,099,041 1.81%
Bajaj Allianz Life Insurance Company Ltd. 4,009,342 1.42%